Tanswell P - Search Results

1

Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogen.

Seifried E, Oethinger M, Tanswell P, Hoegee-de Nobel E, Nieuwenhuizen W. Seifried E, et al. Among authors: tanswell p. Thromb Haemost. 1993 Apr 1;69(4):321-7. Thromb Haemost. 1993. PMID: 8497843

2

Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction.

Tanswell P, Tebbe U, Neuhaus KL, Gläsle-Schwarz L, Wojcik J, Seifried E. Tanswell P, et al. J Am Coll Cardiol. 1992 Apr;19(5):1071-5. doi: 10.1016/0735-1097(92)90297-z. J Am Coll Cardiol. 1992. PMID: 1372625 Free article.

3

Thrombolysis using consecutive high dose bolus and infusion of alteplase in a patient with acute massive pulmonary embolism.

Tebbe U, Seifried E, Carlsson J, Tanswell P. Tebbe U, et al. Among authors: tanswell p. Blood Coagul Fibrinolysis. 1992 Aug;3(4):475-80. Blood Coagul Fibrinolysis. 1992. PMID: 1420824

4

Studies on the functionality of fibrinogen during rt-PA therapy: results of three different methods of fibrinogen determination.

Seifried E, Oethinger M, Tanswell P, Hoegee-de Nobel H, Nieuwenhuizen W. Seifried E, et al. Among authors: tanswell p. Blood Coagul Fibrinolysis. 1992 Feb;3(1):81-7. doi: 10.1097/00001721-199202000-00012. Blood Coagul Fibrinolysis. 1992. PMID: 1623123

5

Comparison of specific antibody, D-Phe-Pro-Arg-CH2Cl and aprotinin for prevention of in vitro effects of recombinant tissue-type plasminogen activator on haemostasis parameters.

Seifried E, Tanswell P. Seifried E, et al. Among authors: tanswell p. Thromb Haemost. 1987 Oct 28;58(3):921-6. Thromb Haemost. 1987. PMID: 2448890

6

Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction.

Seifried E, Tanswell P, Ellbrück D, Haerer W, Schmidt A. Seifried E, et al. Among authors: tanswell p. Thromb Haemost. 1989 Jun 30;61(3):497-501. Thromb Haemost. 1989. PMID: 2508258

7

Current developments in thrombolytic therapy using novel plasminogen activators.

Seifried E, Tanswell P. Seifried E, et al. Among authors: tanswell p. Arzneimittelforschung. 1989 Nov;39(11):1474-82. Arzneimittelforschung. 1989. PMID: 2695093 Review.

8

[Recombinant tissue-type plasminogen activator: pharmacokinetics and effect on the hemostasis system of the human].

Seifried E, Böck F, Tanswell P, Rijken DC, Kluft C, Heimpel H. Seifried E, et al. Among authors: tanswell p. Klin Wochenschr. 1988;66 Suppl 12:40-9. Klin Wochenschr. 1988. PMID: 2450222 German.

9

Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction.

Tebbe U, Tanswell P, Seifried E, Feuerer W, Scholz KH, Herrmann KS. Tebbe U, et al. Among authors: tanswell p. Am J Cardiol. 1989 Sep 1;64(8):448-53. doi: 10.1016/0002-9149(89)90419-0. Am J Cardiol. 1989. PMID: 2505604

10

Fibrin degradation products are not specific markers for thrombolysis in myocardial infarction.

Seifried E, Tanswell P, Rijken DC, Kluft C, Hoegee E, Nieuwenhuizen W. Seifried E, et al. Among authors: tanswell p. Lancet. 1987 Aug 8;2(8554):333-4. doi: 10.1016/s0140-6736(87)90919-6. Lancet. 1987. PMID: 2886790 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters